| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Reed RL 2nd | |
| R. L. Reed | |||
| P2860 | cites work | Candida infections in surgical patients | Q70436357 |
| Treatment of infections due to methicillin-resistant Staphylococcus aureus | Q70444797 | ||
| The rational and irrational use of systemic antimicrobial drugs | Q70486795 | ||
| Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract | Q70502550 | ||
| Laboratory evaluation of the serum dilution test in serious staphylococcal infection | Q70831745 | ||
| Fungal infections complicating acute leukemia | Q70907925 | ||
| Initial aminoglycoside levels in the critically ill | Q71098846 | ||
| The prophylaxis of stress ulceration | Q71130269 | ||
| Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function | Q71135148 | ||
| Inadequacy of recommended tobramycin dosages | Q71140841 | ||
| Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill | Q71288588 | ||
| Analysis of serum bactericidal activity in endocarditis, osteomyelitis, and other bacterial infections | Q71446498 | ||
| Colonization of the gastric contents in critically ill patients | Q72108965 | ||
| -Lactamase stability of cefotaxime | Q72865399 | ||
| Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo) | Q72865483 | ||
| Polypeptide synthesis with ribosomes from streptomycin-resistant and dependent E. coli | Q79387569 | ||
| Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin | Q69733688 | ||
| Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care | Q69743203 | ||
| Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients? | Q69870815 | ||
| Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis | Q69882543 | ||
| Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay | Q69933606 | ||
| An experimental study of susceptibility to infection after hemorrhagic shock | Q69937861 | ||
| Reliability of criteria for predicting persistent or recurrent sepsis | Q70048104 | ||
| Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues | Q70141397 | ||
| Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration | Q70209502 | ||
| Increased burn patient survival with individualized dosages of gentamicin | Q70277778 | ||
| Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa | Q70332650 | ||
| Antibiotic prophylaxis and cardiac surgery. A prospective double-blind comparison of single-dose versus multiple-dose regimens | Q70377210 | ||
| Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia | Q70386358 | ||
| The life and times of the Enterococcus | Q24616875 | ||
| Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 | Q24671879 | ||
| Vancomycin therapy of bacterial endocarditis | Q28319898 | ||
| Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes | Q28360287 | ||
| Drug therapy. Beta-lactam antibiotics (2). | Q30462187 | ||
| Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome | Q33441514 | ||
| Analysis of the Biochemical Mechanism of Drug Resistance in Certain Bacterial Mutants | Q33712794 | ||
| Prophylactic antibiotics in surgery. Practices within surgical services of the Veterans Administration | Q33749174 | ||
| Efficacy of short-course antibiotic prophylaxis after penetrating intestinal injury. A prospective randomized trial | Q34196109 | ||
| Prevention of gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. I. Effect on the colonization pattern of the upper respiratory tract of seriously ill patients | Q34514118 | ||
| In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin | Q34519808 | ||
| Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications | Q34563999 | ||
| Effects of Membrane-Energy Mutations and Cations on Streptomycin and Gentamicin Accumulation by Bacteria: a Model for Entry of Streptomycin and Gentamicin in Susceptible and Resistant Bacteria | Q34984041 | ||
| National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria | Q35296051 | ||
| Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice | Q35648045 | ||
| Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus | Q35669530 | ||
| Interactions between aminoglycoside antibiotics and carbenicillin or ticarcillin | Q39103545 | ||
| Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients | Q39189232 | ||
| Bacteremia due to methicillin-resistant Staphylococcus aureus | Q39355702 | ||
| Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates | Q39408544 | ||
| H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials | Q39428666 | ||
| Stomach as source of bacteria colonising respiratory tract during artificial ventilation | Q39515978 | ||
| Candida infections in the intensive care unit. | Q39524975 | ||
| Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985. | Q39589831 | ||
| Antimicrobial Drug Usage in General Hospitals in Pennsylvania | Q39632158 | ||
| Nosocomial infection surveillance | Q39719754 | ||
| Fever and infection in leukemic patients.A study of 494 consecutive patients | Q39720501 | ||
| Cefamandole and cefoxitin | Q39821788 | ||
| In vitro activity of imipenem--a review | Q40192467 | ||
| A study of antimicrobial misuse in a university hospital | Q40272041 | ||
| Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa | Q40283275 | ||
| The aerobic gram-negative bacillary pneumonias. | Q40286183 | ||
| Criteria for in vitro susceptibility testing of cefotetan. Correlations with clinical and bacteriologic responses | Q68142419 | ||
| Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: sucralfate versus antacids | Q68192769 | ||
| Variability in aminoglycoside pharmacokinetics in critically ill surgical patients | Q68287019 | ||
| Nosocomial Pneumonia in Intubated Patients | Q68352561 | ||
| Empirical antimicrobial therapy in the neutropenic host | Q68891378 | ||
| General principles of antimicrobial therapy | Q69235512 | ||
| Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients | Q69387065 | ||
| Nosocomial fungemia in a large community teaching hospital | Q69463465 | ||
| Prevention of pneumonia in an intensive care unit: a randomized multicenter clinical trial. Intensive Care Unit Group of Infection Control | Q69502622 | ||
| Emergence of isolates resistant to ampicillin | Q69714387 | ||
| The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics | Q40576484 | ||
| Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole | Q40791794 | ||
| A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia | Q40805848 | ||
| Fungal infections in patients with acute leukemia | Q40841874 | ||
| Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. | Q40846628 | ||
| Implications of leukocytosis and fever at conclusion of antibiotic therapy for intra-abdominal sepsis | Q40847994 | ||
| Prophylactic and Preventive Antibiotic Therapy Timing, Duration and Economics | Q41060936 | ||
| Hospital-acquired fungemia. Its natural course and clinical significance | Q41074494 | ||
| Ecthyma gangrenosum: survival with individualized antibiotic therapy | Q41604611 | ||
| Properties of novel beta-lactamase produced by Bacteroides fragilis | Q41881083 | ||
| Susceptibilities of enterococci to twelve antibiotics | Q41956354 | ||
| Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia | Q42008775 | ||
| Vancomycin Ototoxicity in a Patient with Normal Renal Function | Q42269595 | ||
| Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections | Q43417790 | ||
| What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin? | Q43741118 | ||
| Preventing lower airway colonization and infection in mechanically ventilated patients. | Q43784893 | ||
| Infection control in critical care units | Q43833218 | ||
| Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study | Q44453805 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Therapeutic antibiotic monitoring: surveillance using a computerized expert system | Q44494814 | ||
| Mechanisms of resistance to aminoglycosides | Q44529362 | ||
| Skin carriage of antibiotic-resistant coagulase-negative staphylococci in untreated subjects | Q44984202 | ||
| Influence of amikacin as the primary aminoglycoside on bacterial isolates in the intensive care unit. | Q46410189 | ||
| A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections | Q46815200 | ||
| The Nature of the "Irreducible Minimum" Rate of Incisional Sepsis | Q46818611 | ||
| Reducing sepsis in severe combined acute renal and respiratory failure by selective decontamination of the digestive tract. | Q51728462 | ||
| The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. | Q52695343 | ||
| Kinetic model for gentamicin dosing with the use of individual patient parameters | Q52859214 | ||
| Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. | Q53731412 | ||
| Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. | Q54079065 | ||
| Single dose systemic antibiotic prophylaxis of surgical wound infections. | Q54143037 | ||
| Duration of antibiotic prophylaxis. An experimental study. | Q54148191 | ||
| Rapid bacterial screening in the treatment of civilian wounds. | Q54256257 | ||
| Delayed wound closure based on bacterial counts. | Q54354966 | ||
| Cross-resistance and imipenem. | Q54424049 | ||
| Aminoglycoside resistance: a worldwide perspective. | Q54426431 | ||
| Beta-lactams and imipenem. | Q54429658 | ||
| Activity of cefotetan against anaerobic bacteria. | Q54430538 | ||
| Carbapenems: special properties contributing to their activity. | Q54448572 | ||
| Do beta-lactamases 'trap' cephalosporins? | Q54451001 | ||
| Development of resistance to -lactam antibiotics with special reference to third-generation cephalosporins | Q54469669 | ||
| Five-year surveillance of aminoglycoside usage in a university hospital. | Q54480084 | ||
| Fungemia with compromised host resistance. A study of 70 cases. | Q54638326 | ||
| Nosocomial Pneumonia in Intubated Patients Given Sucralfate as Compared with Antacids or Histamine Type 2 Blockers | Q58486075 | ||
| Antibiotic Accountability | Q66833089 | ||
| Staphylococcus epidermidis: an important pathogen | Q66917314 | ||
| Problems in the diagnosis and treatment of systemic candidiasis | Q67269591 | ||
| Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis | Q67281381 | ||
| Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology | Q67582325 | ||
| Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients | Q67779622 | ||
| Prevention of colonization and infection in critically ill patients: a prospective randomized study | Q67928358 | ||
| More is better. Antibiotic management after hemorrhagic shock | Q67946286 | ||
| Duration of preventive antibiotic administration for open extremity fractures | Q68126605 | ||
| Eradication of Candida burn wound septicemia in massively burned patients | Q68128664 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intensive care unit | Q5094647 |
| surgery | Q40821 | ||
| P304 | page(s) | 765-789 | |
| P577 | publication date | 1991-08-01 | |
| P1433 | published in | Surgical Clinics of North America | Q15765820 |
| P1476 | title | Antibiotic choices in surgical intensive care unit patients | |
| Antibiotic Choices in Surgical Intensive Care Unit Patients | |||
| P478 | volume | 71 |
Search more.